Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PRQR

ProQR Therapeutics

$6.48

-0.625 (-8.80%)

07:02
06/12/18
06/12
07:02
06/12/18
07:02
Hot Stocks
ProQR Therapeutics receives up to $5M in partnership to develop QR-313 »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
PRQR

ProQR Therapeutics

$3.50

0.2 (6.06%)

17:31
04/12/18
04/12
17:31
04/12/18
17:31
Hot Stocks
Breaking Hot Stocks news story on ProQR Therapeutics »

Aescap Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

$2.95

-0.025 (-0.84%)

06:30
04/05/18
04/05
06:30
04/05/18
06:30
Initiation
ProQR Therapeutics initiated at Chardan »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
PRQR

ProQR Therapeutics

$3.45

0.05 (1.47%)

07:06
02/28/18
02/28
07:06
02/28/18
07:06
Earnings
ProQR Therapeutics reports Q4 EPS (EUR0.39) vs. (EUR0.38) a year ago »

At December 31, 2017,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

PRQR

ProQR Therapeutics

$3.50

0.05 (1.45%)

09:25
02/19/18
02/19
09:25
02/19/18
09:25
Conference/Events
ProQR Therapeutics to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PRQR

ProQR Therapeutics

$3.20

0.075 (2.40%)

11:32
02/15/18
02/15
11:32
02/15/18
11:32
Conference/Events
ProQR Therapeutics to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PRQR

ProQR Therapeutics

$2.90

-0.15 (-4.92%)

07:12
02/12/18
02/12
07:12
02/12/18
07:12
Hot Stocks
FFB to provide up to $7.5M in funding to develop ProQR's QR-421a »

Foundation Fighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PRQR

ProQR Therapeutics

$3.03

0.025 (0.83%)

07:55
01/23/18
01/23
07:55
01/23/18
07:55
Conference/Events
ProQR Therapeutics to h old an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 19

    Feb

PRQR

ProQR Therapeutics

$3.03

0.025 (0.83%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
ProQR Therapeutics to h old an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 19

    Feb

PRQR

ProQR Therapeutics

$3.00

(0.00%)

13:31
01/19/18
01/19
13:31
01/19/18
13:31
Conference/Events
ProQR Therapeutics to h old an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.